MINDBODY Inc (NASDAQ:MB) insider Bradford Lee Wills sold 8,172 shares of the stock in a transaction on Thursday, March 16th. The stock was sold at an average price of $27.80, for a total value of $227,181.60. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.
Bradford Lee Wills also recently made the following trade(s):
Shares of MINDBODY Inc (NASDAQ:MB) opened at 27.50 on Wednesday. MINDBODY Inc has a 12-month low of $11.91 and a 12-month high of $28.25. The firm has a 50 day moving average price of $25.83 and a 200 day moving average price of $21.98. The stock’s market cap is $1.12 billion.
MINDBODY (NASDAQ:MB) last posted its quarterly earnings data on Wednesday, February 8th. The company reported ($0.04) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.04. The company earned $38.20 million during the quarter, compared to analysts’ expectations of $38.17 million. MINDBODY had a negative return on equity of 22.49% and a negative net margin of 16.53%. MINDBODY’s revenue for the quarter was up 35.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.17) earnings per share. On average, equities analysts expect that MINDBODY Inc will post ($0.10) EPS for the current year.
MB has been the subject of several research reports. Roth Capital set a $26.00 price target on MINDBODY and gave the stock a “buy” rating in a research note on Sunday, December 25th. Craig Hallum began coverage on MINDBODY in a research note on Monday, December 5th. They issued a “buy” rating and a $28.00 target price for the company. Zacks Investment Research downgraded MINDBODY from a “buy” rating to a “hold” rating in a research note on Tuesday, February 7th. Finally, Imperial Capital raised their target price on MINDBODY from $25.00 to $30.00 and gave the stock an “outperform” rating in a research note on Thursday, February 9th. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $24.63.
Hedge funds have recently bought and sold shares of the stock. Luxor Capital Group LP boosted its stake in MINDBODY by 1,168.8% in the fourth quarter. Luxor Capital Group LP now owns 4,167,998 shares of the company’s stock worth $88,778,000 after buying an additional 3,839,489 shares during the period. Capital World Investors boosted its stake in MINDBODY by 573.1% in the third quarter. Capital World Investors now owns 1,001,276 shares of the company’s stock worth $19,685,000 after buying an additional 852,515 shares during the period. Renaissance Technologies LLC boosted its stake in MINDBODY by 10.9% in the fourth quarter. Renaissance Technologies LLC now owns 636,800 shares of the company’s stock worth $13,564,000 after buying an additional 62,600 shares during the period. Gilder Gagnon Howe & Co. LLC purchased a new stake in MINDBODY during the third quarter worth approximately $5,126,000. Finally, Two Sigma Advisers LP boosted its stake in MINDBODY by 216.2% in the third quarter. Two Sigma Advisers LP now owns 251,397 shares of the company’s stock worth $4,942,000 after buying an additional 171,897 shares during the period. Institutional investors own 81.13% of the company’s stock.
MINDBODY, Inc is a provider of cloud-based business management software for the wellness services industry and operates as a consumer marketplace with over 51,000 local business subscribers on its platform in over 130 countries and territories. The Company’s subscribers provide a range of wellness services to approximately 28 million active consumers.